Catecholamine [EPC]

Catecholamine [EPC] was reported 82301 times

Drugs of the Catecholamine [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 NO DEVICE MALFUNCTION 60 0.9836
1 APPENDICOLITH 220 0.5685
2 INJECTION SITE PALLOR 127 0.4019
3 VASCULAR ACCESS SITE COMPLICATION 99 0.3929
4 SLEEP DISORDER THERAPY 72 0.3636
5 ANALGESIC THERAPY 70 0.2181
6 DRUG THERAPY 68 0.2006
7 INFUSION SITE DISCHARGE 342 0.1949
8 ADMINISTRATION SITE SWELLING 61 0.1877
9 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 60 0.1724
10 INFUSION SITE MASS 178 0.1638
11 INFUSION SITE BRUISING 327 0.1512
12 INFUSION SITE PRURITUS 458 0.1450
13 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 151 0.1422
14 INFUSION SITE URTICARIA 93 0.1388
15 LAGOPHTHALMOS 56 0.1369
16 HEREDITARY ANGIOEDEMA 1435 0.1336
17 PROPOFOL INFUSION SYNDROME 89 0.1262
18 INFUSION SITE HAEMORRHAGE 386 0.1172
19 INFUSION SITE SWELLING 672 0.1067
20 INFUSION SITE RASH 146 0.1063
21 INJECTION SITE LACERATION 68 0.1061
22 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 92 0.0992
23 INFUSION SITE DISCOMFORT 101 0.0974
24 DRY GANGRENE 60 0.0945
25 ACCIDENTAL EXPOSURE 391 0.0938
26 LIQUID PRODUCT PHYSICAL ISSUE 678 0.0929
27 MATERNAL EXPOSURE DURING DELIVERY 92 0.0928
28 DEVICE FAILURE 1373 0.0901
29 STEROID DEPENDENCE 79 0.0900
30 INFUSION SITE NODULE 86 0.0895
31 TOXIC ANTERIOR SEGMENT SYNDROME 97 0.0889
32 CATARRH 79 0.0874
33 VASOPLEGIA SYNDROME 139 0.0847
34 STRESS CARDIOMYOPATHY 482 0.0828
35 MULTIPLE ALLERGIES 643 0.0819
36 INFUSION SITE EXTRAVASATION 490 0.0786
37 INFUSION SITE ERYTHEMA 630 0.0747
38 ADMINISTRATION SITE PAIN 86 0.0746
39 INJECTION SITE COLDNESS 63 0.0743
40 INFUSION SITE PAIN 920 0.0713
41 VASOCONSTRICTION 61 0.0697
42 INCORRECT DRUG ADMINISTRATION RATE 291 0.0683
43 INFUSION SITE IRRITATION 84 0.0654
44 MAST CELL ACTIVATION SYNDROME 91 0.0648
45 KOUNIS SYNDROME 147 0.0647
46 DEVICE INFUSION ISSUE 159 0.0641
47 INSURANCE ISSUE 969 0.0633
48 INFUSION SITE WARMTH 74 0.0604
49 INFUSION SITE DISCOLOURATION 53 0.0602
50 DISTRIBUTIVE SHOCK 133 0.0587
51 INJECTION SITE HYPOAESTHESIA 83 0.0580
52 SEASONAL ALLERGY 805 0.0568
53 BLOOD PHOSPHORUS INCREASED 155 0.0567
54 CARDIOGENIC SHOCK 801 0.0558
55 HYPERPHOSPHATAEMIA 109 0.0507
56 BURNS SECOND DEGREE 87 0.0495
57 INFUSION SITE REACTION 147 0.0492
58 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 107 0.0487
59 ARTHROPOD STING 81 0.0486
60 PULSELESS ELECTRICAL ACTIVITY 202 0.0483
61 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 63 0.0466
62 POOR VENOUS ACCESS 478 0.0461
63 PHARYNGEAL SWELLING 445 0.0454
64 HYPERLACTACIDAEMIA 116 0.0432
65 EXTREMITY NECROSIS 73 0.0418
66 VENTRICULAR FIBRILLATION 464 0.0417
67 HAEMODYNAMIC INSTABILITY 315 0.0413
68 SINUSITIS 4117 0.0401
69 EAR INFECTION 1049 0.0394
70 BRASH SYNDROME 55 0.0392
71 PERIPHERAL ISCHAEMIA 160 0.0391
72 ARTERIOSPASM CORONARY 156 0.0388
73 NOROVIRUS INFECTION 55 0.0381
74 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 125 0.0377
75 INFUSION SITE INDURATION 55 0.0371
76 OBSTRUCTION 144 0.0360
77 CHRONIC SINUSITIS 135 0.0359
78 DIABETES INSIPIDUS 85 0.0353
79 DERMATITIS CONTACT 401 0.0351
80 BLOOD PH DECREASED 60 0.0351
81 FOOD ALLERGY 266 0.0344
82 RESPIRATORY TRACT INFECTION 891 0.0342
83 UPPER RESPIRATORY TRACT INFECTION 1562 0.0338
84 VEIN RUPTURE 56 0.0334
85 HYPOPNOEA 115 0.0331
86 VENTRICULAR HYPOKINESIA 106 0.0330
87 BODY TEMPERATURE ABNORMAL 60 0.0326
88 EXPIRED DRUG ADMINISTERED 160 0.0323
89 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 81 0.0309
90 ANAESTHETIC COMPLICATION 83 0.0309
91 RESPIRATORY ACIDOSIS 121 0.0307
92 OXYGEN SATURATION ABNORMAL 86 0.0303
93 COMPARTMENT SYNDROME 79 0.0303
94 CENTRAL VENOUS CATHETERISATION 91 0.0301
95 PRODUCT DISTRIBUTION ISSUE 279 0.0300
96 MULTIPLE ORGAN DYSFUNCTION SYNDROME 852 0.0300
97 RHINITIS 242 0.0300
98 PRODUCT COLOUR ISSUE 151 0.0294
99 RESPIRATORY TRACT INFECTION VIRAL 68 0.0292
100 PHARYNGITIS STREPTOCOCCAL 315 0.0291
101 ANAPHYLACTIC REACTION 1605 0.0290
102 HYPERCAPNIA 86 0.0285
103 CATHETER SITE PAIN 74 0.0285
104 ANIMAL BITE 75 0.0281
105 MYASTHENIA GRAVIS 227 0.0281
106 GASTROENTERITIS VIRAL 507 0.0281
107 APPENDICITIS 262 0.0280
108 METHAEMOGLOBINAEMIA 63 0.0272
109 PARANASAL SINUS DISCOMFORT 103 0.0272
110 VENTRICULAR TACHYCARDIA 442 0.0267
111 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 137 0.0267
112 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 181 0.0266
113 IMPAIRED QUALITY OF LIFE 378 0.0263
114 STREPTOCOCCAL INFECTION 143 0.0257
115 IRON DEFICIENCY 113 0.0251
116 SHOCK 576 0.0250
117 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 126 0.0249
118 STRIDOR 73 0.0248
119 BRONCHIECTASIS 167 0.0248
120 WEIGHT FLUCTUATION 256 0.0244
121 BLOOD URIC ACID INCREASED 141 0.0244
122 SKIN ABRASION 115 0.0243
123 SKIN INFECTION 265 0.0236
124 TROPONIN INCREASED 178 0.0234
125 BLOOD LACTIC ACID INCREASED 123 0.0233
126 PRODUCT PACKAGING CONFUSION 56 0.0230
127 VENTRICULAR ARRHYTHMIA 84 0.0229
128 BLOOD IMMUNOGLOBULIN E INCREASED 55 0.0227
129 TOOTH INFECTION 299 0.0227
130 BRONCHITIS 1678 0.0226
131 LYME DISEASE 75 0.0225
132 VASCULAR DEVICE INFECTION 102 0.0225
133 EYE INFECTION 253 0.0224
134 HEPARIN-INDUCED THROMBOCYTOPENIA 110 0.0223
135 MULTI-ORGAN FAILURE 383 0.0221
136 ACIDOSIS 169 0.0221
137 PULSE ABSENT 104 0.0218
138 RHINOVIRUS INFECTION 85 0.0218
139 NEEDLE ISSUE 615 0.0211
140 VIRAL INFECTION 695 0.0209
141 GASTROINTESTINAL INFECTION 187 0.0208
142 SKIN LACERATION 226 0.0208
143 ARTHROPOD BITE 154 0.0208
144 INJECTION SITE INJURY 114 0.0205
145 PSEUDOMONAS INFECTION 174 0.0203
146 UPPER-AIRWAY COUGH SYNDROME 167 0.0202
147 MENINGITIS ASEPTIC 91 0.0202
148 APLASTIC ANAEMIA 104 0.0199
149 RESPIRATORY SYNCYTIAL VIRUS INFECTION 173 0.0198
150 SINUS DISORDER 392 0.0198
151 FOOD POISONING 106 0.0198
152 BRAIN DEATH 61 0.0197
153 FORCED EXPIRATORY VOLUME DECREASED 55 0.0194
154 SUSPECTED COVID-19 64 0.0194
155 HORDEOLUM 83 0.0192
156 BACTERIAL INFECTION 357 0.0191
157 INFUSION RELATED REACTION 1264 0.0191
158 ACUTE RESPIRATORY DISTRESS SYNDROME 334 0.0189
159 SINUS TACHYCARDIA 268 0.0189
160 METABOLIC ACIDOSIS 602 0.0188
161 ISCHAEMIA 86 0.0187
162 FEAR 498 0.0185
163 PRODUCT ADMINISTRATION INTERRUPTED 144 0.0183
164 KIDNEY INFECTION 359 0.0183
165 HYPOPHOSPHATAEMIA 134 0.0181
166 RHINITIS ALLERGIC 80 0.0180
167 CARDIAC ARREST 1471 0.0178
168 LEFT VENTRICULAR DYSFUNCTION 119 0.0177
169 AORTIC STENOSIS 61 0.0175
170 GASTRIC INFECTION 66 0.0172
171 HYPERVOLAEMIA 85 0.0172
172 SINUS CONGESTION 232 0.0172
173 INTESTINAL ISCHAEMIA 93 0.0169
174 CARDIAC MURMUR 146 0.0169
175 PRE-EXISTING CONDITION IMPROVED 105 0.0168
176 TOOTH ABSCESS 170 0.0167
177 ASTHMA 1875 0.0166
178 RALES 96 0.0165
179 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 282 0.0164
180 OLIGURIA 102 0.0164
181 BREATH SOUNDS ABNORMAL 81 0.0164
182 NEPHROGENIC ANAEMIA 76 0.0164
183 SUPRAVENTRICULAR TACHYCARDIA 157 0.0164
184 ANURIA 141 0.0164
185 BRADYCARDIA 868 0.0163
186 TENDERNESS 170 0.0163
187 PHARYNGITIS 202 0.0163
188 PAROSMIA 122 0.0162
189 ANAPHYLACTIC SHOCK 416 0.0161
190 ELECTROCARDIOGRAM ABNORMAL 126 0.0160
191 BLOOD PRESSURE SYSTOLIC DECREASED 73 0.0160
192 PARANASAL SINUS HYPERSECRETION 61 0.0160
193 ILLNESS 1638 0.0159
194 ORAL INFECTION 62 0.0158
195 OBSTRUCTIVE AIRWAYS DISORDER 176 0.0158
196 CANDIDA INFECTION 267 0.0158
197 CIRCULATORY COLLAPSE 269 0.0158
198 COVID-19 2764 0.0157
199 COVID-19 PNEUMONIA 185 0.0157
200 CONCUSSION 121 0.0156
201 RESPIRATORY TRACT CONGESTION 246 0.0155
202 CARDIOTOXICITY 138 0.0155
203 SWOLLEN TONGUE 483 0.0154
204 SEPTIC SHOCK 672 0.0154
205 POST PROCEDURAL INFECTION 125 0.0154
206 VITAMIN B12 DEFICIENCY 62 0.0153
207 LARYNGEAL OEDEMA 94 0.0152
208 LIGAMENT SPRAIN 150 0.0152
209 TORSADE DE POINTES 119 0.0152
210 SINUS BRADYCARDIA 146 0.0151
211 LOW BIRTH WEIGHT BABY 120 0.0151
212 BRAIN FOG 236 0.0150
213 LACTIC ACIDOSIS 482 0.0149
214 HYPOXIA 524 0.0149
215 POST-TRAUMATIC STRESS DISORDER 98 0.0146
216 PATENT DUCTUS ARTERIOSUS 58 0.0146
217 RENAL INJURY 429 0.0144
218 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 242 0.0142
219 SPUTUM DISCOLOURED 135 0.0142
220 BRONCHOSPASM 203 0.0142
221 CYSTITIS 443 0.0139
222 POST PROCEDURAL COMPLICATION 267 0.0139
223 ACUTE PULMONARY OEDEMA 78 0.0139
224 SKIN NECROSIS 72 0.0139
225 MOUTH SWELLING 80 0.0139
226 VEIN DISORDER 69 0.0138
227 VENTRICULAR EXTRASYSTOLES 143 0.0138
228 THROAT TIGHTNESS 370 0.0137
229 WRONG PRODUCT ADMINISTERED 92 0.0136
230 PRODUCTIVE COUGH 650 0.0136
231 FUNGAL INFECTION 453 0.0136
232 PRODUCT QUALITY ISSUE 1843 0.0136
233 ANGIOEDEMA 600 0.0135
234 PULMONARY HAEMORRHAGE 106 0.0135
235 LOCALISED INFECTION 326 0.0135
236 INFLUENZA 1502 0.0135
237 KLEBSIELLA INFECTION 68 0.0134
238 ANHEDONIA 353 0.0134
239 LIMB INJURY 364 0.0134
240 ESCHERICHIA INFECTION 110 0.0134
241 GANGRENE 80 0.0133
242 RIGHT VENTRICULAR FAILURE 93 0.0133
243 PNEUMONIA BACTERIAL 121 0.0132
244 ARTHRITIS INFECTIVE 61 0.0131
245 ATRIOVENTRICULAR BLOCK FIRST DEGREE 57 0.0131
246 SENSITIVE SKIN 97 0.0131
247 BLOOD PRESSURE DIASTOLIC DECREASED 97 0.0131
248 MYOCARDIAL ISCHAEMIA 149 0.0131
249 HYPOTENSION 2613 0.0130
250 DISSEMINATED INTRAVASCULAR COAGULATION 181 0.0128
251 WHEEZING 760 0.0128
252 PHARYNGEAL OEDEMA 197 0.0128
253 BRAIN INJURY 128 0.0128
254 HEART RATE ABNORMAL 71 0.0127
255 INJURY ASSOCIATED WITH DEVICE 259 0.0127
256 GINGIVAL PAIN 101 0.0127
257 STAPHYLOCOCCAL INFECTION 417 0.0126
258 ACUTE RESPIRATORY FAILURE 243 0.0126
259 NASOPHARYNGITIS 2327 0.0126
260 RESPIRATORY DISTRESS 347 0.0126
261 VITAMIN D DEFICIENCY 122 0.0125
262 URINARY TRACT INFECTION 2116 0.0124
263 RESPIRATORY DEPRESSION 152 0.0124
264 COAGULOPATHY 206 0.0124
265 TOXIC EPIDERMAL NECROLYSIS 186 0.0122
266 MIGRAINE 1168 0.0122
267 NASAL CONGESTION 713 0.0121
268 CARDIOMYOPATHY 179 0.0121
269 ATELECTASIS 117 0.0121
270 DEVICE RELATED INFECTION 186 0.0121
271 BLOOD PRESSURE ABNORMAL 240 0.0121
272 TACHYCARDIA 1072 0.0121
273 NORMAL NEWBORN 65 0.0119
274 SUSPECTED OFF LABEL USE 54 0.0119
275 PARAESTHESIA ORAL 172 0.0119
276 URTICARIA 1996 0.0119
277 LIP SWELLING 396 0.0119
278 HAND FRACTURE 84 0.0118
279 EAR DISORDER 54 0.0118
280 PREMATURE DELIVERY 186 0.0117
281 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2103 0.0117
282 ENDOPHTHALMITIS 70 0.0117
283 PRODUCT DOSE OMISSION ISSUE 3412 0.0116
284 SCRATCH 122 0.0116
285 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 603 0.0115
286 BUNDLE BRANCH BLOCK RIGHT 53 0.0115
287 EXPIRED PRODUCT ADMINISTERED 382 0.0115
288 TOXIC ENCEPHALOPATHY 58 0.0114
289 ASCITES 336 0.0114
290 JOINT INJURY 244 0.0114
291 ATRIAL FLUTTER 91 0.0114
292 SENSITIVITY TO WEATHER CHANGE 60 0.0114
293 NEURALGIA 277 0.0114
294 RENAL TUBULAR NECROSIS 111 0.0113
295 SINUS HEADACHE 67 0.0113
296 THERMAL BURN 80 0.0113
297 URINE OUTPUT DECREASED 98 0.0112
298 SEPSIS 1240 0.0111
299 POSTOPERATIVE WOUND INFECTION 75 0.0111
300 OROPHARYNGEAL DISCOMFORT 100 0.0111
301 HYPOVOLAEMIA 64 0.0109
302 RESPIRATORY FAILURE 796 0.0109
303 TACHYPNOEA 148 0.0109
304 MUSCLE STRAIN 94 0.0109
305 ELECTROCARDIOGRAM QT PROLONGED 388 0.0108
306 ASPIRATION 118 0.0108
307 ATRIOVENTRICULAR BLOCK COMPLETE 72 0.0107
308 SCAR 184 0.0107
309 RESPIRATION ABNORMAL 74 0.0107
310 PNEUMOTHORAX 169 0.0106
311 DEVICE USE ISSUE 186 0.0106
312 FOOT FRACTURE 201 0.0106
313 ACCIDENTAL EXPOSURE TO PRODUCT 1091 0.0106
314 INTENTIONAL PRODUCT USE ISSUE 926 0.0106
315 LIVE BIRTH 88 0.0105
316 CONJUNCTIVITIS 195 0.0105
317 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 576 0.0105
318 RESPIRATORY DISORDER 314 0.0105
319 PULMONARY OEDEMA 468 0.0104
320 EAR PAIN 203 0.0104
321 BRAIN OEDEMA 131 0.0104
322 BACTERAEMIA 123 0.0104
323 NASAL DISCOMFORT 82 0.0103
324 INJECTION SITE DISCOLOURATION 129 0.0103
325 PULMONARY CONGESTION 136 0.0103
326 SEROTONIN SYNDROME 198 0.0103
327 ULCER 163 0.0102
328 UNEVALUABLE EVENT 775 0.0102
329 GENERALISED TONIC-CLONIC SEIZURE 169 0.0102
330 INFECTION 1475 0.0102
331 MITRAL VALVE INCOMPETENCE 115 0.0102
332 BLOOD PRESSURE DECREASED 673 0.0101
333 PRODUCT DOSE OMISSION IN ERROR 286 0.0101
334 ATRIOVENTRICULAR BLOCK 78 0.0101
335 INABILITY TO AFFORD MEDICATION 100 0.0101
336 HEART RATE INCREASED 997 0.0101
337 ASPERGILLUS INFECTION 66 0.0100
338 INJECTION SITE DISCHARGE 54 0.0100
339 OXYGEN SATURATION DECREASED 564 0.0100
340 GINGIVITIS 54 0.0100
341 PULMONARY MASS 149 0.0100
342 CLOSTRIDIUM DIFFICILE INFECTION 217 0.0099
343 THROAT IRRITATION 444 0.0099
344 HYPERLIPIDAEMIA 118 0.0099
345 INJURY 694 0.0099
346 BODY TEMPERATURE DECREASED 97 0.0098
347 ORAL CANDIDIASIS 129 0.0098
348 WOUND INFECTION 107 0.0098
349 HYPERAESTHESIA 80 0.0097
350 PNEUMONIA 3148 0.0097
351 RESPIRATORY RATE INCREASED 86 0.0097
352 BLOOD UREA INCREASED 162 0.0097
353 CYANOSIS 152 0.0097
354 BODY TEMPERATURE INCREASED 197 0.0096
355 PULMONARY HYPERTENSION 201 0.0096
356 SKIN WARM 56 0.0096
357 SWELLING 900 0.0096
358 PLEURISY 57 0.0096
359 WRIST FRACTURE 115 0.0096
360 PERIORBITAL SWELLING 54 0.0095
361 CHEST DISCOMFORT 974 0.0095
362 FLANK PAIN 89 0.0095
363 MYDRIASIS 121 0.0094
364 OROPHARYNGEAL PAIN 871 0.0094
365 CELLULITIS 473 0.0094
366 SNEEZING 210 0.0094
367 BODY HEIGHT DECREASED 100 0.0093
368 LEUKOCYTOSIS 169 0.0093
369 AUTOIMMUNE DISORDER 91 0.0093
370 SLEEP APNOEA SYNDROME 178 0.0093
371 TEMPERATURE INTOLERANCE 95 0.0092
372 FACIAL PARALYSIS 78 0.0091
373 EJECTION FRACTION DECREASED 142 0.0091
374 NEPHROLITHIASIS 418 0.0091
375 PARALYSIS 130 0.0091
376 DECUBITUS ULCER 74 0.0091
377 FACIAL PAIN 81 0.0091
378 UNRESPONSIVE TO STIMULI 234 0.0091
379 STATUS EPILEPTICUS 102 0.0090
380 BLOOD PRESSURE SYSTOLIC INCREASED 176 0.0090
381 ORAL HERPES 176 0.0090
382 SARS-COV-2 TEST POSITIVE 119 0.0090
383 CONTUSION 863 0.0090
384 COUGH 2508 0.0089
385 BLOOD MAGNESIUM DECREASED 77 0.0089
386 THERAPY NON-RESPONDER 401 0.0089
387 ADRENAL INSUFFICIENCY 108 0.0089
388 MUSCULOSKELETAL DISCOMFORT 153 0.0089
389 DIVERTICULITIS 246 0.0089
390 APNOEA 69 0.0089
391 HYPERSENSITIVITY 1641 0.0088
392 ECZEMA 461 0.0088
393 PREMATURE BABY 265 0.0088
394 NEUTROPHIL COUNT INCREASED 90 0.0088
395 RENAL FAILURE 1167 0.0088
396 NERVE COMPRESSION 81 0.0088
397 APHONIA 122 0.0087
398 SHOCK HAEMORRHAGIC 71 0.0087
399 CARDIAC FAILURE ACUTE 58 0.0087
400 SECRETION DISCHARGE 109 0.0087
401 HEAD INJURY 275 0.0087
402 MENINGITIS 58 0.0087
403 SPINAL DISORDER 82 0.0086
404 COMA 412 0.0086
405 CHILLS 1010 0.0086
406 HYPOTHERMIA 87 0.0086
407 RHINORRHOEA 553 0.0085
408 BLOOD CALCIUM INCREASED 75 0.0085
409 VITAMIN D DECREASED 73 0.0085
410 BLOOD PRESSURE INCREASED 1304 0.0085
411 ANKLE FRACTURE 132 0.0085
412 HEART RATE DECREASED 299 0.0085
413 IMPAIRED GASTRIC EMPTYING 116 0.0085
414 EMPHYSEMA 85 0.0084
415 ACUTE KIDNEY INJURY 1287 0.0084
416 BRONCHOPULMONARY ASPERGILLOSIS 65 0.0084
417 ACUTE CORONARY SYNDROME 69 0.0083
418 PRODUCT PACKAGING ISSUE 79 0.0083
419 TRICUSPID VALVE INCOMPETENCE 66 0.0083
420 END STAGE RENAL DISEASE 150 0.0082
421 CARPAL TUNNEL SYNDROME 115 0.0082
422 CARDIO-RESPIRATORY ARREST 343 0.0082
423 MIDDLE INSOMNIA 153 0.0082
424 GOUT 147 0.0082
425 PNEUMONIA ASPIRATION 204 0.0082
426 ABDOMINAL DISTENSION 852 0.0082
427 COLITIS ISCHAEMIC 55 0.0081
428 FULL BLOOD COUNT ABNORMAL 85 0.0080
429 SPINAL OPERATION 99 0.0080
430 ACUTE MYOCARDIAL INFARCTION 235 0.0080
431 BLOOD ALBUMIN DECREASED 63 0.0079
432 BLOOD IRON DECREASED 94 0.0079
433 DYSPNOEA EXERTIONAL 298 0.0079
434 HYPOAESTHESIA ORAL 118 0.0078
435 PALLOR 213 0.0078
436 RENAL IMPAIRMENT 657 0.0078
437 FIBROMYALGIA 190 0.0078
438 HEADACHE 4886 0.0078
439 LUNG INFECTION 121 0.0078
440 DECREASED ACTIVITY 84 0.0078
441 EYELID PTOSIS 79 0.0078
442 PYREXIA 2679 0.0077
443 RIB FRACTURE 159 0.0077
444 SWELLING FACE 502 0.0077
445 MUSCULOSKELETAL CHEST PAIN 119 0.0077
446 HYPERKALAEMIA 269 0.0077
447 MASS 107 0.0076
448 PULMONARY THROMBOSIS 83 0.0076
449 DERMATITIS ATOPIC 400 0.0076
450 THROMBOSIS 610 0.0076
451 INTERVERTEBRAL DISC DEGENERATION 70 0.0076
452 INTENTIONAL OVERDOSE 485 0.0076
453 HERNIA 146 0.0075
454 LACRIMATION INCREASED 227 0.0075
455 BACK DISORDER 122 0.0075
456 HIATUS HERNIA 97 0.0075
457 DEVICE OCCLUSION 105 0.0075
458 EYE INFLAMMATION 71 0.0074
459 GENERALISED OEDEMA 92 0.0074
460 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 191 0.0074
461 EYE SWELLING 276 0.0074
462 MUSCLE TIGHTNESS 120 0.0074
463 EAR DISCOMFORT 76 0.0074
464 TOOTH FRACTURE 81 0.0073
465 ROTATOR CUFF SYNDROME 94 0.0073
466 MENTAL STATUS CHANGES 203 0.0073
467 DYSPNOEA 4137 0.0073
468 POST PROCEDURAL HAEMORRHAGE 85 0.0073
469 INJECTION SITE EXTRAVASATION 90 0.0073
470 FEELING JITTERY 139 0.0073
471 WRONG DRUG ADMINISTERED 65 0.0073
472 ACCIDENTAL OVERDOSE 266 0.0073
473 PRODUCT USE IN UNAPPROVED INDICATION 1795 0.0072
474 COMPLICATION ASSOCIATED WITH DEVICE 105 0.0072
475 BLOOD POTASSIUM DECREASED 217 0.0072
476 IMPAIRED WORK ABILITY 154 0.0072
477 PALPITATIONS 843 0.0072
478 SLEEP DISORDER 508 0.0072
479 PROCEDURAL COMPLICATION 55 0.0072
480 PRODUCT AVAILABILITY ISSUE 163 0.0072
481 NECK PAIN 398 0.0071
482 HERPES ZOSTER 408 0.0071
483 INJECTION SITE SWELLING 544 0.0071
484 BLOOD PRESSURE FLUCTUATION 170 0.0071
485 OSTEOMYELITIS 128 0.0071
486 ATRIAL FIBRILLATION 688 0.0071
487 OEDEMA 383 0.0071
488 HAEMOPTYSIS 196 0.0070
489 BLOOD POTASSIUM INCREASED 114 0.0070
490 PRODUCT USE ISSUE 1319 0.0070
491 ENCEPHALOPATHY 172 0.0070
492 SENSATION OF FOREIGN BODY 59 0.0070
493 MATERNAL EXPOSURE DURING PREGNANCY 624 0.0070
494 PERIPHERAL COLDNESS 96 0.0070
495 ELECTROLYTE IMBALANCE 81 0.0070
496 POOR QUALITY SLEEP 150 0.0070
497 UROSEPSIS 64 0.0069
498 THERAPY CHANGE 68 0.0069
499 INFLUENZA LIKE ILLNESS 569 0.0069
500 CARDIOMEGALY 85 0.0069
501 FEELING COLD 192 0.0069
502 RENAL FAILURE CHRONIC 53 0.0069
503 VERTIGO 420 0.0069
504 EXPOSURE DURING PREGNANCY 428 0.0069
505 PRODUCT ADMINISTRATION ERROR 139 0.0069
506 HAEMOLYSIS 53 0.0069
507 LOWER RESPIRATORY TRACT INFECTION 312 0.0069
508 WEIGHT DECREASED 1915 0.0069
509 FREQUENT BOWEL MOVEMENTS 185 0.0068
510 EYE PRURITUS 230 0.0068
511 CONDITION AGGRAVATED 2080 0.0068
512 DEPRESSED LEVEL OF CONSCIOUSNESS 269 0.0068
513 HYPONATRAEMIA 380 0.0067
514 EOSINOPHIL COUNT INCREASED 56 0.0067
515 IRON DEFICIENCY ANAEMIA 62 0.0067
516 RHABDOMYOLYSIS 280 0.0067
517 ANXIETY 1909 0.0067
518 PRODUCT PRESCRIBING ISSUE 146 0.0067
519 FURUNCLE 53 0.0067
520 SEIZURE 769 0.0067
521 CHEST PAIN 1232 0.0066
522 DYSPHONIA 388 0.0066
523 CYST 82 0.0066
524 ARTHRITIS 519 0.0066
525 GASTROOESOPHAGEAL REFLUX DISEASE 530 0.0066
526 BLOOD CALCIUM DECREASED 74 0.0066
527 SCAB 75 0.0066
528 INTENTIONAL DOSE OMISSION 187 0.0066
529 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 315 0.0066
530 BLOOD TEST ABNORMAL 92 0.0065
531 FALL 2178 0.0065
532 BLOOD SODIUM DECREASED 123 0.0065
533 HAEMATOMA 169 0.0065
534 GASTROINTESTINAL DISORDER 582 0.0065
535 LOSS OF CONSCIOUSNESS 830 0.0065
536 TOXICITY TO VARIOUS AGENTS 1091 0.0065
537 LUNG DISORDER 317 0.0065
538 HYSTERECTOMY 56 0.0065
539 PRESCRIBED OVERDOSE 125 0.0065
540 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 57 0.0064
541 BLADDER DISORDER 64 0.0064
542 PULMONARY EMBOLISM 611 0.0064
543 HEAD DISCOMFORT 113 0.0064
544 HYPERBILIRUBINAEMIA 66 0.0064
545 LYMPHADENOPATHY 225 0.0063
546 TUBULOINTERSTITIAL NEPHRITIS 119 0.0063
547 HYPERTENSION 1341 0.0063
548 PROCEDURAL PAIN 175 0.0063
549 MICTURITION URGENCY 72 0.0063
550 ARRHYTHMIA 297 0.0063
551 TINNITUS 288 0.0063
552 INTERVERTEBRAL DISC PROTRUSION 137 0.0063
553 RASH MACULAR 219 0.0063
554 WHITE BLOOD CELL COUNT INCREASED 240 0.0062
555 SYSTEMIC LUPUS ERYTHEMATOSUS 222 0.0062
556 RENAL FAILURE ACUTE 265 0.0062
557 PRURITUS 2397 0.0062
558 DRUG INEFFECTIVE 8212 0.0062
559 CLOSTRIDIUM DIFFICILE COLITIS 66 0.0062
560 CATARACT 370 0.0062
561 WEIGHT INCREASED 1391 0.0062
562 PAIN 3810 0.0062
563 INJECTION SITE DISCOMFORT 65 0.0062
564 PLEURAL EFFUSION 374 0.0061
565 ROAD TRAFFIC ACCIDENT 257 0.0061
566 CYTOKINE RELEASE SYNDROME 123 0.0061
567 DISCOMFORT 374 0.0061
568 UPPER LIMB FRACTURE 122 0.0061
569 SKIN SWELLING 53 0.0061
570 HEPATOMEGALY 60 0.0061
571 PERICARDIAL EFFUSION 141 0.0061
572 PRODUCT USE COMPLAINT 96 0.0061
573 SMALL INTESTINAL OBSTRUCTION 75 0.0061
574 HEPATIC FAILURE 183 0.0061
575 BACK INJURY 66 0.0061
576 HYPOKALAEMIA 280 0.0061
577 BLOOD LACTATE DEHYDROGENASE INCREASED 96 0.0061
578 JOINT DISLOCATION 64 0.0060
579 FEELING HOT 371 0.0060
580 BACK PAIN 1405 0.0060
581 SKIN DISCOLOURATION 277 0.0060
582 DYSPHAGIA 572 0.0060
583 FATIGUE 4688 0.0060
584 BURNING SENSATION 422 0.0060
585 LIMB DISCOMFORT 186 0.0060
586 HYPERSOMNIA 172 0.0060
587 NERVOUS SYSTEM DISORDER 187 0.0060
588 PANIC ATTACK 218 0.0060
589 FLUID OVERLOAD 87 0.0060
590 THYROID DISORDER 92 0.0060
591 QUALITY OF LIFE DECREASED 80 0.0060
592 RESTLESS LEGS SYNDROME 108 0.0059
593 FEEDING DISORDER 120 0.0059
594 COLD SWEAT 104 0.0059
595 DRY EYE 293 0.0059
596 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 56 0.0059
597 TOOTHACHE 106 0.0058
598 HYPOKINESIA 85 0.0058
599 SKIN CANCER 126 0.0058
600 HYPERTENSIVE CRISIS 65 0.0058
601 ABSCESS 93 0.0058
602 MUSCULAR WEAKNESS 659 0.0058
603 HEART RATE IRREGULAR 131 0.0058
604 PERIPHERAL SWELLING 889 0.0058
605 BURSITIS 70 0.0058
606 IMMUNE SYSTEM DISORDER 76 0.0058
607 NERVE INJURY 64 0.0058
608 PREGNANCY 115 0.0057
609 RASH PRURITIC 311 0.0057
610 SKIN HAEMORRHAGE 85 0.0057
611 RASH ERYTHEMATOUS 274 0.0057
612 TRANSFUSION 60 0.0057
613 LYMPHOCYTE COUNT DECREASED 101 0.0057
614 MYOCLONUS 68 0.0057
615 LETHARGY 328 0.0057
616 OCULAR DISCOMFORT 64 0.0057
617 KNEE OPERATION 56 0.0057
618 HAEMATOCRIT DECREASED 112 0.0056
619 INJECTION SITE URTICARIA 138 0.0056
620 TREMOR 932 0.0056
621 VOMITING 2638 0.0056
622 RASH 2442 0.0056
623 DRUG EFFECT LESS THAN EXPECTED 83 0.0056
624 OBESITY 89 0.0056
625 SCIATICA 89 0.0056
626 ERYTHEMA 1146 0.0056
627 FLUSHING 564 0.0055
628 DEHYDRATION 739 0.0055
629 ABDOMINAL PAIN 1285 0.0055
630 COORDINATION ABNORMAL 77 0.0055
631 SKELETAL INJURY 57 0.0055
632 PRESYNCOPE 134 0.0055
633 LIVER FUNCTION TEST INCREASED 118 0.0055
634 EYE DISCHARGE 57 0.0055
635 ECONOMIC PROBLEM 83 0.0055
636 SKIN FISSURES 107 0.0055
637 WOUND 153 0.0055
638 SPINAL FRACTURE 109 0.0054
639 BLOOD CREATININE INCREASED 355 0.0054
640 SOMNOLENCE 1093 0.0054
641 INJECTION SITE BRUISING 433 0.0054
642 SYNCOPE 539 0.0054
643 CARDIAC DISORDER 501 0.0053
644 BIPOLAR DISORDER 58 0.0053
645 CHOLESTASIS 102 0.0053
646 LOWER LIMB FRACTURE 102 0.0053
647 EATING DISORDER 113 0.0053
648 DEEP VEIN THROMBOSIS 344 0.0053
649 CHOKING 103 0.0053
650 INJECTION SITE PRURITUS 353 0.0053
651 EPISTAXIS 394 0.0053
652 GALLBLADDER DISORDER 94 0.0053
653 PHOTOPHOBIA 99 0.0053
654 RED BLOOD CELL COUNT DECREASED 150 0.0052
655 NAUSEA 4141 0.0052
656 DRY MOUTH 424 0.0052
657 TOOTH EXTRACTION 65 0.0052
658 BLISTER 293 0.0052
659 INJECTION SITE PAIN 1595 0.0052
660 PAIN IN EXTREMITY 1531 0.0052
661 MALNUTRITION 58 0.0052
662 DIPLOPIA 134 0.0052
663 ASPARTATE AMINOTRANSFERASE INCREASED 274 0.0052
664 OSTEOPOROSIS 211 0.0051
665 GLOMERULAR FILTRATION RATE DECREASED 63 0.0051
666 TRANSIENT ISCHAEMIC ATTACK 172 0.0051
667 HYPOAESTHESIA 763 0.0051
668 INJECTION SITE ERYTHEMA 631 0.0051
669 CHOLECYSTECTOMY 58 0.0051
670 CHRONIC KIDNEY DISEASE 385 0.0051
671 DEVICE MALFUNCTION 356 0.0051
672 RED BLOOD CELL SEDIMENTATION RATE INCREASED 56 0.0051
673 GASTRITIS 133 0.0050
674 MALAISE 2215 0.0050
675 SPEECH DISORDER 264 0.0050
676 PULMONARY ARTERIAL HYPERTENSION 73 0.0050
677 TOOTH DISORDER 112 0.0050
678 OFF LABEL USE 4398 0.0050
679 GASTROINTESTINAL PAIN 55 0.0050
680 HYPERHIDROSIS 644 0.0050
681 HAEMORRHOIDS 97 0.0050
682 ALANINE AMINOTRANSFERASE INCREASED 305 0.0050
683 DRUG INTERACTION 786 0.0049
684 MEDICATION ERROR 275 0.0049
685 IRRITABLE BOWEL SYNDROME 106 0.0049
686 DIABETES MELLITUS 376 0.0049
687 SURGERY 289 0.0049
688 THERAPEUTIC RESPONSE SHORTENED 163 0.0049
689 BLOOD CHOLESTEROL INCREASED 229 0.0049
690 ILEUS 61 0.0049
691 NODULE 64 0.0049
692 DELIRIUM 170 0.0049
693 UPPER GASTROINTESTINAL HAEMORRHAGE 82 0.0049
694 RASH PAPULAR 109 0.0049
695 ACCIDENT 58 0.0049
696 INTESTINAL OBSTRUCTION 182 0.0048
697 THERAPY INTERRUPTED 345 0.0048
698 COLITIS 183 0.0048
699 NIGHTMARE 167 0.0048
700 INJECTION SITE HAEMATOMA 70 0.0048
701 INJECTION SITE RASH 148 0.0048
702 EYELID OEDEMA 56 0.0048
703 FLUID RETENTION 245 0.0048
704 GENERAL PHYSICAL HEALTH DETERIORATION 557 0.0048
705 TRANSAMINASES INCREASED 107 0.0048
706 DYSARTHRIA 181 0.0048
707 ARTHRALGIA 1997 0.0048
708 DIZZINESS 2387 0.0048
709 HEPATIC STEATOSIS 89 0.0048
710 IMMUNODEFICIENCY 71 0.0048
711 INJECTION SITE HAEMORRHAGE 380 0.0048
712 DYSURIA 175 0.0047
713 RECTAL HAEMORRHAGE 204 0.0047
714 HYPERGLYCAEMIA 173 0.0047
715 MUSCLE SPASMS 869 0.0047
716 PHOTOSENSITIVITY REACTION 78 0.0047
717 HAEMATOCHEZIA 260 0.0047
718 NEOPLASM 54 0.0047
719 BLOOD CREATINE PHOSPHOKINASE INCREASED 135 0.0047
720 PARAESTHESIA 736 0.0047
721 NEUROPATHY PERIPHERAL 443 0.0047
722 SKIN DISORDER 155 0.0046
723 ABDOMINAL DISCOMFORT 779 0.0046
724 NERVOUSNESS 242 0.0046
725 FEELING ABNORMAL 1108 0.0046
726 EMOTIONAL DISTRESS 558 0.0046
727 SPINAL PAIN 54 0.0046
728 OCULAR HYPERAEMIA 218 0.0046
729 PAIN IN JAW 130 0.0046
730 FOETAL EXPOSURE DURING PREGNANCY 372 0.0046
731 THERAPEUTIC RESPONSE DECREASED 277 0.0046
732 CARDIAC FAILURE 366 0.0046
733 RETCHING 97 0.0045
734 OEDEMA PERIPHERAL 554 0.0045
735 ACUTE HEPATIC FAILURE 62 0.0045
736 DERMATITIS 95 0.0045
737 INJECTION SITE IRRITATION 57 0.0045
738 DRUG LEVEL INCREASED 74 0.0045
739 HAEMATEMESIS 113 0.0045
740 HIP FRACTURE 143 0.0044
741 BLOOD BILIRUBIN INCREASED 120 0.0044
742 INJECTION SITE REACTION 305 0.0044
743 BALANCE DISORDER 383 0.0044
744 EYE PAIN 250 0.0044
745 BLOOD URINE PRESENT 84 0.0044
746 COLITIS ULCERATIVE 197 0.0044
747 DISABILITY 87 0.0044
748 RESPIRATORY ARREST 121 0.0044
749 DEPRESSION 998 0.0044
750 AGITATION 322 0.0044
751 HYPOPHAGIA 112 0.0044
752 EYE DISORDER 144 0.0044
753 SKIN LESION 120 0.0044
754 THROMBOCYTOPENIA 489 0.0044
755 MENTAL DISORDER 190 0.0044
756 HAEMORRHAGE 454 0.0043
757 RENAL DISORDER 202 0.0043
758 FACE OEDEMA 73 0.0043
759 BLOOD ALKALINE PHOSPHATASE INCREASED 107 0.0043
760 DEVICE ISSUE 386 0.0043
761 HYPERCALCAEMIA 53 0.0043
762 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 305 0.0043
763 CONSTIPATION 935 0.0043
764 ANAEMIA 816 0.0043
765 EYE IRRITATION 246 0.0043
766 RASH MACULO-PAPULAR 95 0.0043
767 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 144 0.0043
768 INCORRECT PRODUCT ADMINISTRATION DURATION 92 0.0042
769 INJECTION SITE INDURATION 55 0.0042
770 KNEE ARTHROPLASTY 89 0.0042
771 INTRAOCULAR PRESSURE INCREASED 54 0.0042
772 INFLAMMATION 218 0.0042
773 PULMONARY FIBROSIS 81 0.0042
774 NO ADVERSE EVENT 765 0.0042
775 LYMPHOMA 65 0.0042
776 OSTEOARTHRITIS 178 0.0042
777 TENDONITIS 65 0.0042
778 COGNITIVE DISORDER 196 0.0042
779 ABDOMINAL PAIN UPPER 863 0.0042
780 LOCAL SWELLING 73 0.0042
781 HAEMOGLOBIN DECREASED 429 0.0042
782 NEUROTOXICITY 73 0.0042
783 CARDIAC FAILURE CONGESTIVE 334 0.0042
784 ALTERED STATE OF CONSCIOUSNESS 90 0.0042
785 INJECTION SITE MASS 153 0.0041
786 CHOLELITHIASIS 135 0.0041
787 GASTROENTERITIS 60 0.0041
788 EOSINOPHILIA 72 0.0041
789 ASTHENIA 1539 0.0041
790 DIALYSIS 58 0.0041
791 THIRST 73 0.0041
792 MYALGIA 694 0.0041
793 MEMORY IMPAIRMENT 559 0.0041
794 NIGHT SWEATS 131 0.0041
795 GASTRIC ULCER 77 0.0040
796 DEVICE DEFECTIVE 70 0.0040
797 BASAL CELL CARCINOMA 63 0.0040
798 INJECTION SITE WARMTH 83 0.0040
799 INTENTIONAL PRODUCT MISUSE 351 0.0040
800 GLAUCOMA 77 0.0040
801 DIARRHOEA 2580 0.0040
802 MUSCULOSKELETAL STIFFNESS 350 0.0040
803 DEPRESSED MOOD 211 0.0040
804 C-REACTIVE PROTEIN INCREASED 145 0.0040
805 SKIN REACTION 56 0.0040
806 APHASIA 120 0.0040
807 CHROMATURIA 89 0.0039
808 CRYING 143 0.0039
809 SKIN EXFOLIATION 331 0.0039
810 HYPOGLYCAEMIA 187 0.0039
811 HEMIPARESIS 65 0.0038
812 OSTEOPENIA 58 0.0038
813 PANCREATITIS 202 0.0038
814 POLLAKIURIA 159 0.0038
815 HAEMORRHAGE INTRACRANIAL 57 0.0038
816 CORONARY ARTERY DISEASE 115 0.0038
817 DEVICE LEAKAGE 163 0.0038
818 FEBRILE NEUTROPENIA 249 0.0037
819 CONFUSIONAL STATE 604 0.0037
820 BONE DISORDER 68 0.0037
821 INSOMNIA 992 0.0037
822 THERAPEUTIC RESPONSE UNEXPECTED 167 0.0037
823 GAIT DISTURBANCE 709 0.0037
824 VISION BLURRED 506 0.0037
825 DRUG ADMINISTRATION ERROR 113 0.0037
826 CEREBROVASCULAR ACCIDENT 622 0.0037
827 ORAL PAIN 82 0.0037
828 GAIT INABILITY 122 0.0036
829 SKIN ULCER 94 0.0036
830 PNEUMONITIS 99 0.0036
831 EMOTIONAL DISORDER 112 0.0036
832 DRY SKIN 483 0.0036
833 PSYCHOMOTOR HYPERACTIVITY 60 0.0036
834 SUICIDE ATTEMPT 219 0.0036
835 TASTE DISORDER 73 0.0036
836 THERAPEUTIC PRODUCT EFFECT DECREASED 161 0.0036
837 EXPOSURE VIA SKIN CONTACT 93 0.0036
838 BONE PAIN 210 0.0036
839 JOINT STIFFNESS 94 0.0036
840 JOINT SWELLING 432 0.0036
841 CEREBRAL HAEMORRHAGE 128 0.0036
842 BLOOD TRIGLYCERIDES INCREASED 63 0.0036
843 MUSCLE TWITCHING 82 0.0036
844 INCORRECT ROUTE OF DRUG ADMINISTRATION 127 0.0035
845 HEPATIC ENZYME INCREASED 241 0.0035
846 PANCREATITIS ACUTE 79 0.0035
847 DRUG INTOLERANCE 339 0.0035
848 GASTROINTESTINAL HAEMORRHAGE 293 0.0035
849 FAECES DISCOLOURED 76 0.0035
850 HOSPITALISATION 537 0.0035
851 HYPOCALCAEMIA 66 0.0035
852 DYSPEPSIA 343 0.0035
853 URINARY RETENTION 116 0.0035
854 HEPATOTOXICITY 77 0.0035
855 INTERNATIONAL NORMALISED RATIO INCREASED 98 0.0034
856 MENTAL IMPAIRMENT 83 0.0034
857 PRURITUS GENERALISED 74 0.0034
858 MUSCULOSKELETAL PAIN 179 0.0034
859 TYPE 2 DIABETES MELLITUS 115 0.0034
860 PRODUCT PREPARATION ERROR 70 0.0034
861 OVERDOSE 730 0.0034
862 DISTURBANCE IN ATTENTION 181 0.0034
863 INCORRECT DOSE ADMINISTERED 765 0.0033
864 MOUTH ULCERATION 70 0.0033
865 URINARY INCONTINENCE 98 0.0033
866 HOT FLUSH 249 0.0033
867 LIVER DISORDER 146 0.0033
868 HYPOTHYROIDISM 105 0.0033
869 RESTLESSNESS 120 0.0033
870 IMPAIRED HEALING 107 0.0033
871 DYSSTASIA 95 0.0033
872 DECREASED APPETITE 755 0.0032
873 DRUG EFFECT INCOMPLETE 117 0.0032
874 ADVERSE DRUG REACTION 289 0.0032
875 DISORIENTATION 127 0.0032
876 TREATMENT NONCOMPLIANCE 175 0.0032
877 PHARMACEUTICAL PRODUCT COMPLAINT 83 0.0032
878 UNDERDOSE 233 0.0032
879 CARDIOVASCULAR DISORDER 81 0.0032
880 PLATELET COUNT DECREASED 339 0.0032
881 STEVENS-JOHNSON SYNDROME 70 0.0031
882 BLOOD GLUCOSE ABNORMAL 58 0.0031
883 ARTHROPATHY 174 0.0031
884 AMNESIA 203 0.0031
885 MOVEMENT DISORDER 100 0.0031
886 MOBILITY DECREASED 221 0.0031
887 VISUAL IMPAIRMENT 381 0.0031
888 BLINDNESS 124 0.0030
889 SYRINGE ISSUE 53 0.0030
890 DYSKINESIA 123 0.0030
891 ISCHAEMIC STROKE 54 0.0030
892 ABDOMINAL PAIN LOWER 76 0.0030
893 BLOOD GLUCOSE DECREASED 144 0.0030
894 ILL-DEFINED DISORDER 182 0.0030
895 DRUG ERUPTION 53 0.0030
896 PELVIC PAIN 54 0.0030
897 MYOCARDIAL INFARCTION 517 0.0030
898 LIVER FUNCTION TEST ABNORMAL 86 0.0030
899 DEAFNESS 77 0.0029
900 NEOPLASM MALIGNANT 195 0.0029
901 DYSGEUSIA 217 0.0029
902 GASTRIC DISORDER 99 0.0029
903 FULL BLOOD COUNT DECREASED 58 0.0029
904 ANGER 97 0.0029
905 MELAENA 63 0.0029
906 GLYCOSYLATED HAEMOGLOBIN INCREASED 72 0.0028
907 LIVER INJURY 70 0.0028
908 DRUG DOSE OMISSION BY DEVICE 222 0.0028
909 IRRITABILITY 170 0.0028
910 RASH GENERALISED 73 0.0028
911 STOMATITIS 169 0.0028
912 CEREBRAL INFARCTION 68 0.0028
913 HAEMATURIA 95 0.0028
914 DRUG RESISTANCE 71 0.0028
915 HEPATIC FUNCTION ABNORMAL 103 0.0028
916 WRONG TECHNIQUE IN DRUG USAGE PROCESS 100 0.0027
917 FLATULENCE 154 0.0027
918 LABORATORY TEST ABNORMAL 80 0.0027
919 DEVICE BREAKAGE 110 0.0027
920 SKIN IRRITATION 124 0.0027
921 MULTIPLE SCLEROSIS 129 0.0027
922 JAUNDICE 72 0.0027
923 FEMUR FRACTURE 82 0.0026
924 SUICIDAL IDEATION 242 0.0026
925 SEDATION 69 0.0026
926 THERAPY CESSATION 135 0.0026
927 VISUAL ACUITY REDUCED 87 0.0026
928 ANGINA PECTORIS 75 0.0026
929 DEMENTIA 73 0.0026
930 PAIN OF SKIN 70 0.0026
931 PRODUCT COMPLAINT 65 0.0026
932 TREATMENT FAILURE 211 0.0025
933 PRODUCT DISPENSING ERROR 55 0.0025
934 HYPOACUSIS 108 0.0025
935 PANCYTOPENIA 140 0.0025
936 DEVICE DELIVERY SYSTEM ISSUE 68 0.0025
937 GAMMA-GLUTAMYLTRANSFERASE INCREASED 55 0.0025
938 HEPATITIS 63 0.0025
939 RHEUMATOID ARTHRITIS 278 0.0024
940 LEUKOPENIA 121 0.0024
941 PSYCHOTIC DISORDER 71 0.0024
942 MUCOSAL INFLAMMATION 61 0.0023
943 ABNORMAL BEHAVIOUR 91 0.0023
944 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 464 0.0023
945 ALOPECIA 448 0.0023
946 MOOD ALTERED 62 0.0023
947 PRODUCT PRESCRIBING ERROR 54 0.0023
948 PSORIATIC ARTHROPATHY 92 0.0023
949 NEUTROPHIL COUNT DECREASED 92 0.0023
950 WHITE BLOOD CELL COUNT DECREASED 240 0.0022
951 AGEUSIA 55 0.0022
952 EXTRA DOSE ADMINISTERED 88 0.0022
953 WITHDRAWAL SYNDROME 91 0.0022
954 MOOD SWINGS 68 0.0021
955 DISEASE PROGRESSION 251 0.0021
956 DRUG DOSE OMISSION 349 0.0021
957 ABNORMAL DREAMS 58 0.0021
958 PRODUCT STORAGE ERROR 183 0.0021
959 DRUG EXPOSURE DURING PREGNANCY 71 0.0021
960 PRODUCT SUBSTITUTION ISSUE 120 0.0021
961 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 97 0.0021
962 PRODUCT DOSE OMISSION 135 0.0021
963 CONTRAINDICATED PRODUCT ADMINISTERED 62 0.0020
964 CONVULSION 117 0.0020
965 AGGRESSION 102 0.0020
966 DEATH 1744 0.0020
967 EPILEPSY 60 0.0020
968 SKIN BURNING SENSATION 138 0.0019
969 BLOOD GLUCOSE INCREASED 361 0.0019
970 DRUG-INDUCED LIVER INJURY 60 0.0019
971 NEUTROPENIA 258 0.0019
972 HALLUCINATION 142 0.0019
973 ABORTION SPONTANEOUS 75 0.0019
974 DRUG EFFECT DECREASED 96 0.0018
975 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 126 0.0018
976 PSORIASIS 229 0.0018
977 ACNE 131 0.0017
978 OSTEONECROSIS 54 0.0016
979 MULTIPLE SCLEROSIS RELAPSE 109 0.0016
980 DEVICE DISLOCATION 69 0.0016
981 PLASMA CELL MYELOMA 61 0.0016
982 DISEASE RECURRENCE 73 0.0015
983 INTERSTITIAL LUNG DISEASE 73 0.0015
984 ADVERSE EVENT 133 0.0014
985 LUNG NEOPLASM MALIGNANT 55 0.0013
986 DEVICE DIFFICULT TO USE 88 0.0013
987 VAGINAL HAEMORRHAGE 56 0.0013
988 BREAST CANCER 117 0.0013
989 DRUG ABUSE 87 0.0010
990 COMPLETED SUICIDE 79 0.0009
991 DRUG WITHDRAWAL SYNDROME 79 0.0009
992 MALIGNANT NEOPLASM PROGRESSION 91 0.0009
993 DRUG DEPENDENCE 87 0.0005